Literature DB >> 29063963

Does Oxidative Stress Play a Role in Altered Characteristics of Diabetic Bone? A Systematic Review.

Miljana Bacevic1,2, Bozidar Brkovic2, Adelin Albert3, Eric Rompen4, Regis P Radermecker5, France Lambert6,7,8.   

Abstract

Diabetes mellitus (DM) has been associated with increased bone fracture rates, impaired bone regeneration, delayed bone healing, and depressed osteogenesis. However, the plausible pathogenic mechanisms remain incompletely understood. The aim of the present systematic review was to investigate whether oxidative stress (OS) plays a role in altered characteristics of diabetic bone under in vivo conditions. An electronic search of the MEDLINE (via PubMed) and Embase databases was performed. In vivo animal studies involving DM and providing information regarding assessment of OS markers combined with analyses of bone histology/histomorphometry parameters were selected. A descriptive analysis of selected articles was performed. Ten studies were included in the present review. Both bone formation and bone resorption parameters were significantly decreased in the diabetic groups of animals compared to the healthy groups. This finding was consistent regardless of different animal/bone models employed or different evaluation periods. A statistically significant increase in systemic and/or local OS status was also emphasised in the diabetic groups in comparison to the healthy ones. Markers of OS were associated with histological and/or histomorphometric parameters, including decreased trabecular bone and osteoid volumes, suppressed bone formation, defective bone mineralisation, and reduced osteoclastic activity, in diabetic animals. Additionally, insulin and antioxidative treatment proved to be efficient in reversing the deleterious effects of high glucose and associated OS. The present findings support the hypotheses that OS in the diabetic condition contributes at least partially to defective bone features, and that antioxidative supplementation can be a valuable adjunctive strategy in treating diabetic bone disease, accelerating bone healing, and improving osteointegration.

Entities:  

Keywords:  Antioxidants; Bone features; Diabetes mellitus; Oxidative stress; Review

Mesh:

Year:  2017        PMID: 29063963     DOI: 10.1007/s00223-017-0327-7

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  8 in total

1.  S-allylmercapto-N-acetylcysteine protects bone cells from oxidation and improves femur microarchitecture in healthy and diabetic mice.

Authors:  Reem Abu-Kheit; Shlomo Kotev-Emeth; Sahar Hiram-Bab; Yankel Gabet; Naphtali Savion
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

2.  Hyponatremia Is Associated With Increased Osteoporosis and Bone Fractures in Patients With Diabetes With Matched Glycemic Control.

Authors:  Rachel L Usala; Stephen J Fernandez; Mihriye Mete; Nawar M Shara; Joseph G Verbalis
Journal:  J Endocr Soc       Date:  2019-01-04

Review 3.  4-Hydroxy-2-nonenal, a lipid peroxidation product, as a biomarker in diabetes and its complications: challenges and opportunities.

Authors:  Deiva Dham; Bipradas Roy; Amita Gowda; Guodong Pan; Arun Sridhar; Xiangqun Zeng; Rajarajan A Thandavarayan; Suresh Selvaraj Palaniyandi
Journal:  Free Radic Res       Date:  2021-01-07

4.  N-Acetylcysteine (NAC) Ameliorates Lipid-Related Metabolic Dysfunction in Bone Marrow Stromal Cells-Derived Adipocytes.

Authors:  Marco Raffaele; Ignazio Barbagallo; Maria Licari; Giuseppe Carota; Giuseppe Sferrazzo; Mariarita Spampinato; Valeria Sorrenti; Luca Vanella
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-17       Impact factor: 2.629

5.  Effect of the lipoxygenase inhibitor baicalein on bone tissue and bone healing in ovariectomized rats.

Authors:  Marina Komrakova; Stephan Sehmisch; Dominik Saul; Marie Weber; Marc Hendrik Zimmermann; Robyn Laura Kosinsky; Daniel Bernd Hoffmann; Björn Menger; Stefan Taudien; Wolfgang Lehmann
Journal:  Nutr Metab (Lond)       Date:  2019-01-11       Impact factor: 4.169

6.  Chondroitin Sulfate Prevents STZ Induced Diabetic Osteoporosis through Decreasing Blood Glucose, AntiOxidative Stress, Anti-Inflammation and OPG/RANKL Expression Regulation.

Authors:  Hong Xing Zheng; De Jing Chen; Yue Xin Zu; En Zhu Wang; Shan Shan Qi
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

7.  Impairment of type H vessels by NOX2-mediated endothelial oxidative stress: critical mechanisms and therapeutic targets for bone fragility in streptozotocin-induced type 1 diabetic mice.

Authors:  Xiao-Fan Hu; Geng Xiang; Tian-Ji Wang; Yu-Bo Ma; Yang Zhang; Ya-Bo Yan; Xiong Zhao; Zi-Xiang Wu; Ya-Fei Feng; Wei Lei
Journal:  Theranostics       Date:  2021-01-30       Impact factor: 11.556

8.  TiO2 Nanotubes Alleviate Diabetes-Induced Osteogenetic Inhibition.

Authors:  Jinghong Yang; Hui Zhang; Sin Man Chan; Ruoqi Li; Yu Wu; Min Cai; Anxun Wang; Yan Wang
Journal:  Int J Nanomedicine       Date:  2020-05-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.